| NDC Code | 72769-102-01 |
|---|
| Package Description | 4 DOSE PACK in 1 CARTON (72769-102-01) / 1 BLISTER PACK in 1 DOSE PACK / 7 CAPSULE in 1 BLISTER PACK |
|---|
| Product NDC | 72769-102 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Orladeyo |
|---|
| Non-Proprietary Name | Berotralstat Hydrochloride |
|---|
| Dosage Form | CAPSULE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20201204 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA214094 |
|---|
| Manufacturer | BioCryst Pharmaceuticals Inc. |
|---|
| Substance Name | BEROTRALSTAT HYDROCHLORIDE |
|---|
| Strength | 110 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kallikrein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC] |
|---|